Ken Griffin Generation Bio Co. Transaction History

Citadel Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.64 - $4.35 $21,505 - $35,435	-8,146 Reduced 14.14%	49,475 $139,000
Q1 2024 May 15, 2024	SELL	$1.73 - $4.07 $118,607 - $279,035	-68,559 Reduced 54.33%	57,621 $234,000
Q4 2023 Feb 14, 2024	BUY	$0.91 - $3.35 $105,425 - $388,104	115,852 Added 1121.73%	126,180 $208,000
Q3 2023 Nov 14, 2023	SELL	$3.65 - $6.9 $80,175 - $151,565	-21,966 Reduced 68.02%	10,328 $39,000
Q2 2023 Aug 14, 2023	BUY	$3.5 - $5.67 $113,029 - $183,106	32,294 New	32,294 $177,000
Q4 2022 Feb 14, 2023	SELL	$3.66 - $6.77 $37,288 - $68,972	-10,188 Reduced 47.43%	11,294 $44,000
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $155,174 - $276,529	-33,157 Reduced 60.68%	21,482 $114,000
Q2 2022 Aug 15, 2022	BUY	$4.87 - $9.41 $29,955 - $57,880	6,151 Added 12.69%	54,639 $359,000
Q1 2022 May 16, 2022	BUY	$4.16 - $7.76 $82,293 - $153,508	19,782 Added 68.91%	48,488 $356,000
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $56,958 - $237,439	9,509 Added 49.53%	28,706 $203,000
Q2 2021 Aug 16, 2021	SELL	$24.34 - $38.34 $420,741 - $662,745	-17,286 Reduced 47.38%	19,197 $516,000
Q1 2021 May 17, 2021	BUY	$24.74 - $40.2 $902,589 - $1.47 Million	36,483 New	36,483 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$21.68 - $51.61 $289,493 - $689,148	-13,353 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$18.07 - $31.84 $9.57 Million - $16.9 Million	-529,747 Reduced 97.54%	13,353 $413,000
Q2 2020 Aug 14, 2020	BUY	$20.1 - $24.69 $10.9 Million - $13.4 Million	543,100 New	543,100 $11.4 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $79.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.